ERBB2 and neoplasm: We state using only one gene expression microarray for selection of genes, lack of comparison of expression of genes between luminal, HER2+ and TNBC samples and lack of validation in an independent set of tumor/adjacent normal specimens as limitations of our study which should be addressed in future studies.